Expression of inducible lymphocyte costimulatory molecules in human renal allograft

Nephrology Dialysis Transplantation

Volumn 13, Issue 3, 1998, Pages 716-722

  Biancone, Luigi ^a   Segoloni, Giuseppe ^b   Turello, Ernesto ^b   Donati, Donato ^a   Bussolati, Benedetta ^b   Piccoli, Giuseppe ^b   Camussi, Giovanni ^a,c  

^a UNIVERSITY OF PAVIA   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c Dipartimento Discipline Medico Chirurgiche   (Italy)

Author keywords

Costimulatory molecules; Rejection; Transplantation

Indexed keywords

B7 ANTIGEN; CD4 ANTIGEN; CD40 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GLYCOPROTEIN GP 39;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY ALLOGRAFT; KIDNEY ALLOGRAFT REJECTION; KIDNEY BIOPSY; LYMPHOCYTIC INFILTRATION; MALE; PRIORITY JOURNAL;

ADULT; ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, CD86; ANTIGENS, DIFFERENTIATION; BIOPSY; CD40 LIGAND; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOCONJUGATES; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MEMBRANE GLYCOPROTEINS; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 0031930887     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/13.3.716     Document Type: Article

References (27)

1. Bluestone JA. New perspective of CD28-B7-mediated T cell costimulation. Immunity 1995; 2: 555-559
2. Lenschow DJ, Zeng Y, Thistlethwaite JR et al. Long-term survival of xenogeneic pancreatic islets grafts induced by CTLA4 Ig. Science 1992; 257: 789-792
3. Lenschow DJ, Zeng Y, Hathcock KS et al. Inhibition of transplant rejection following treatment with anti-B7-2 and anti-B7-1 antibodies. Transplantation 1995; 60: 1171-1178
4. Linsley PS, Wallace PM, Johnson J et al. Immunosuppression in vivo by a soluble form of the CTLA-4T cell activation molecule. Science 1992; 257: 792-795
5. Hollenbaugh D, Grosmaire LS, Kullas CD et al. The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co-stimulatory activity. EMBO J 1992; 11: 4313-4321
6. Freudenthal PS, Steinman RM. The distinct surface of human blood dendritic cells, as observed after an improved isolation method. Proc Natl Acad Sci USA 1990; 87: 7698-7702
7. Alderson MR, Armitage RJ, Tough TW, Strockbine L, Fanslow WC, Spriggs MK. CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40. J Exp Med 1993; 178: 669-674
8. Hollenbaugh D, Mischel-Petty N, Edwards CP et al. Expression of functional CD40 by vascular endothelial cells. J Exp Med 1995; 182: 33-40
9. Van den Eertwegh AJM, Noelle RJ, Roy M et al. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. I. In vivo expression of CD40 ligand, cytokines, and antibody production delineates sites of cognate T-B cell Interactions. J Exp Med 1993; 178: 1555-1565
10. Allen RC, Armitage RJ, Conley ME et al. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science 1993; 259: 990-993
11. Solez K, Axelsen RA, Benediktsson H et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 1993; 44: 411-422
12. Lin H, Bolling SF, Linsley P et al. Long-term acceptance of major histocompatibility mismatched cardiac allografts induced by CTLA4 Ig plus donor-specific transfusion. J Exp Med 1993; 178: 1801-1806
13. Larsen CP, Elwood ET, Alexander DZ et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 1996; 381: 434-438
14. Sayegh MH, Akalin E, Hancock WW et al. CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. J Exp Med 1995; 181: 1869-1874
15. Biancone L, Andres G, Ahn H et al. Distinct regulatory roles of lymphocytes costimulatory pathways on T helper type 2-mediated autoimmune disease. J Exp Med 1996; 183: 1473-1481
16. Nishikawa K, Linsley P, Collins AB, Stamenkovic I, McCluskey RT, Andres G. Effect of CTLA-4 chimeric protein on rat autoimmune anti-glomerular basement membrane glomerulonephritis. Eur J Immunol 1994; 24: 1249-1255
17. Clark EA, Ledbetter J. How T and B cells talk to each other. Nature 1994; 367: 425-428
18. Larsen CP, Alexander DZ, Hollenbaugh D et al. CD40-gp39 interactions play a critical role during allograft rejection. Suppression of allograft rejection by blockade of the CD40-gp39 pathway. Transplantation 1996; 61 : 4-9
19. Rossini AA, Parker DC, Philips NE et al. Induction of immunological tolerance to islet allografts. Cell Transplant 1996; 5: 49-52
20. Cerottini JC, Brunner KT. Cell mediated cytotoxicity, allograft rejection and tumor immunity. Adv Immunol 1991; 21: 687-703
21. Robertson H, Wheeler J, Kirby JA, Morley AR. Renal allograft rejection - in situ demonstration of cytotoxic intratubular cells. Transplantation 1996; 61: 1546-1556
22. Strehlau J, Pavlakis M, Maslinsky W, Shapiro M, Harmon W, Strom TB. Markers of T-cell activation: gene expression of CTLA-4 and IL-2 and IL-15 receptor a chains in transplant core biopsies. Am J Soc Nephrol 1996; 7: A3387
23. Hall BM. Cells mediating allograft rejection. Transplantation 1991; 51: 1141-1151
24. Krieger NR, DengPing Y, Fathman CG. CD4+ but not CDS+ cells are essential for allorejection. J Exp Med 1996; 184: 2013-2018
25. Wilson JL, Proud G, Forsythe JL, Tayler RM, Kirby JA. Renal allograft rejection. Tubular epithelial cells present alloantigen in the presence of costimulatory CD28 antibody. Transplantation 1995; 59: 91-97
26. Van Cooten C, Gerritsma JS, Paape ME, Van Es LA, Banchereau J, Daha MR. Possible role for CD40-CD40L in the regulation of interstitial infiltration in the kidney. Kidney Int 1997; 51: 711-721
27. Yellin MJ, D'Agati V, Parkinson G et al. Immunohistologic analysis of renal CD40 and CD40L expression in lupus nephritis and other glomerulonephritides Arthritis Rheum. 1997; 40: 124-134